Our Firm is representing a number of clients who have Stryker hip lawsuits pending in this litigation. We are pleased to see that both the litigation and the mediation program is progressing.
New York, New York (PRWEB) June 25, 2014
Mediation efforts continue to make progress in the Stryker hip recall (http://www.strykerhiprecallclaims.com/styker-rejuvenate-hip-recall/) litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Case Management Order issued on June 23rd, five additional Stryker hip lawsuits have been resolved in Phase II of the Early Mediation program. The Order also noted that of 18 cases mediated during Phases I and II of the Program, 17 have been settled. Three more claims are scheduled to undergo mediation within the next 30 days. Finally, the Court is preparing to embark on Phase III of Early Mediation, and has directed the parties to submit a list of eligible cases by July 14th. The Court will announce its selection of Phase III cases by August 4th. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm is representing a number of clients who have Stryker hip lawsuits pending in this litigation. We are pleased to see that both the litigation and the mediation program is progressing,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals were allegedly harmed by Stryker’s Rejuvenate and ABG II Modular-Neck Hip Stems.
Stryker Hip Recall
The Stryker hip recall was announced by the U.S. Food & Drug Administration on July 6, 2012, after data indicated that the Rejuvenate and ABG II Modular-Neck Hip Stems were vulnerable to fretting and corrosion at the modular-neck junction. Stryker has warned that this occurrence places Rejuvenate and ABG II recipients at risk for adverse local tissue reactions, pain and swelling. In addition, the company advised all patients fitted with a recalled component to undergo medical screening to ensure it is working properly, even if they have not experienced any symptoms that would suggest a problem with their implant.*
Since the announcement of the recall, more than 1,581 Stryker hip lawsuits have been filed in New Jersey Superior Court. An additional 970 claims are pending in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244) All of these lawsuits similarly allege that the defective nature of the Rejuvenate and ABG II hip stems caused recipients to suffer chronic pain, metallosis, osteolysis, tissue necrosis, and other complications that resulted in premature failure of their hip implant.
Individuals who were allegedly harmed by Rejuvenate and ABG II hip stems may be eligible to file their own Stryker hip lawsuit. To learn more about the Stryker hip recall, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP